CD14 and TNFα promoter polymorphisms in patients with acute arthritis

References

• Marti M, Alvarez I, Lopez de Castro JA. A molecular insight on the association of HLA-B27 with spondyloarthropathies. Curr Rheumatol Rep 1999;1:78–85.
   Google Scholar
• Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki LM, Suoranta H, Nissila M, et al. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982;25: 249–59.
   Google Scholar
• Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166–70.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson D, Keat A. Septic and aseptic arthritis: a continuum? Baillieres Best Pract Res Clin Rheumatol 1999;13:179–92.
   Google Scholar
• Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249: 1431–3.
   Google Scholar
• Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activa-tion is mediated by toll-like receptor 2. J Biol Chem 1999; 274:17406–9.
   Google Scholar
• Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988;239: 497–500.
   Google Scholar
• Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999;20:976–83.
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, et al. C(_ 260)- T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99:3218–20.
   Google Scholar
• Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999;19:932–8.
   PubMed Web of Science ®Google Scholar
• Shimada K, Watanabe Y, Mokuno H, Iwama Y, Daida H, Yamaguchi H. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 2000;86:682–4.
   PubMed Web of Science ®Google Scholar
• Zee RY, Lindpaintner K, Struk B, Hennekens CH, Ridker PM. A prospective evaluation of the CD14 C(_ 260)T gene polymorphism and the risk of myocardial infarction. Athero-sclerosis 2001;154: 699–702.
   Google Scholar
• Stone MA, Inman RD. The genetics of cytokines in ankylo sing spondylitis. J Rheumatol 2001;28:1203–6.
   PubMedGoogle Scholar
• Verweij CL, Huizinga TW. Tumour necrosis factor alpha gene polymorphisms and rheumatic diseases. Br J Rheumatol 1998;37:923–6.
   PubMedGoogle Scholar
• Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195–9.
   PubMed Web of Science ®Google Scholar
• Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha) _ 308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1995;46: 32–41.
   Google Scholar
• Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, et al. _ 308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995;46:42–50.
   PubMedGoogle Scholar
• Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561–8.
   PubMed Web of Science ®Google Scholar
• Valtonen VV, Leirisalo M, Pentikainen PJ, Rasanen T, Seppala I, Larinkari U, et al. Triggering infections in reactive arthritis. Ann Rheum Dis 1985;44:399–405.
   PubMed Web of Science ®Google Scholar
• Leirisalo-Repo M, Paimela L, Valtonen V, Koskimies S, Pentikainen P. Epidemiology and prognostic features of ReA. Ann Rheum Dis 1996;55:576–7.
   Google Scholar
• Leirisalo-Repo M, Paimela L, Valtonen V, Koskimies S, Pentikainen P. 14-year outcome of patients with early arthritis. Arthritis Rheum ; 1996;39(Suppl):5258.
   Google Scholar
• Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondyl-arthropathy. Arthritis Rheum 1991;34:1218–27.
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361 —8.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• LeVan TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, et al. A common single nucleotide polymorph-ism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001;167:5838 —44.
   PubMedGoogle Scholar
• Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001;33:1148–53.
   PubMed Web of Science ®Google Scholar
• Durieux JJ, Vita N, Popescu O, Guette F, Calzada-Wack J, Munker R, et al. The two soluble forms of the lipopoly-saccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol 1994;24: 2006–12.
   Google Scholar
• Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothe-lial cells. Proc Natl Acad Sci U S A 1993;90: 9887–91.
   Google Scholar
• McGarry F, Walker R, Sturrock R, Field M. The _ 308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis indepen-dent of HLA-B27. J Rheumatol 1999;26:1110–6.
   Google Scholar
• Hohler T, Schaper T, Schneider PM, Meyer zum Buschenfelde KH, Marker-Hermann E. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998;41: 1489–92.
   Google Scholar
• Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A, et al. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001;60:36–42.
   PubMed Web of Science ®Google Scholar
• Braun J, Yin Z, Spiller I, Siegert S, Rudwaleit M, Liu L, et al. Low secretion of tumor necrosis factor alpha, but no other Thl or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 1999;42:2039–44.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Chin Invest 1999;104:503–13.
   PubMed Web of Science ®Google Scholar
• Morishita M, Miyagi M, Iwamoto Y. Effects of sex hormones on production of interleukin-1 by human peripheral mono-cytes. J Periodontol 1999;70: 757–60.
   Google Scholar
• Pervin S, Singh R, Rosenfeld ME, Navab M, Chaudhuri G, Nathan L. Estradiol suppresses MCP-1 expression in vivo: implications for atherosclerosis. Arterioscler Thromb Vasc Biol 1998;18:1575–82.
   PubMed Web of Science ®Google Scholar